Sphera Funds Management’s Soleno Therapeutics SLNO Stock Holding History

Sphera Funds Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-216,281	Closed	-$7.24M	–	122
2026 Q1	$7.24M	Buy	216,281 +79,967	+59%	+$3.14M	1.15%	25
2025 Q4	$6.31M	Buy	136,314 +94,708	+228%	+$5.19M	1.22%	30
2025 Q3	$2.81M	Buy	+41,606	New	+$3.08M	0.59%	57
2020 Q3	–	Sell	-82,245	Closed	-$2.74M	–	111
2020 Q2	$2.74M	Buy	+82,245	New	+$3.56M	0.26%	68

Sphera Funds Management's SLNO Position: Q2 2026 in Review

Sphera Funds Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 216,281 shares — an estimated $7.24M sold.

Sphera Funds Management first reported a position in SLNO in Q2 2020 and held it in 4 quarters. The position peaked at $7.24M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Sphera Funds Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Sphera Funds Management sold 216,281 Soleno Therapeutics shares in Q2 2026, an estimated $7.24M.
Sphera Funds Management first reported a position in Soleno Therapeutics in Q2 2020 and held it in 4 quarters.
Sphera Funds Management's Soleno Therapeutics position peaked at $7.24M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.